Deploy a Turnkey Autologous Program Inside Your Clinic.
Partner with Renagen to implement a non-invasive, in-clinic autologous workflow in coordination with your clinical team. Add a premium offering and recurring biobanking revenue with minimal upfront investment.
Request Strategic Partner Call- Non-invasive workflow
- Standardized SOP system
- Renagen-supported deployment model
We implement the system. Your team retains full clinical authority.
Renagen is not a product company. We implement a structured autologous workflow inside your clinic in coordination with your clinical team. You maintain your patient relationships and full medical authority. We handle the operational and technical backbone.
In-Clinic Implementation
A compact workflow implemented inside your facility. No external lab dependency. No shipping delays. Everything happens on site.
Standardized Workflow
Every step follows validated SOPs. Collection, isolation, expansion, quality control. Repeatable, documented, auditable.
Quality and Traceability
Full chain of custody from sample to final preparation. Digital traceability, batch records, and validation at every stage.
Trained Personnel On-Site
A Renagen-trained biologist runs the workflow inside your clinic. You do not need to hire or train laboratory staff.
Based on peer-reviewed protocols with 200+ supporting publications.
Why Clinics Partner With Renagen
This is not a cost centre. It is a new revenue line for your practice.
Increase Revenue Per Patient
Add premium autologous processing services to your existing patient base. Higher-value visits. Stronger retention.
Recurring Biobank Income
Long-term cryopreservation creates a recurring annual storage revenue stream from every patient who banks their cells.
Minimal Upfront Investment
Renagen supports deployment, workflows, and operational setup. Your clinic contributes space, clinical oversight, and patient flow.
Exclusive Regional Positioning
We select only one partner clinic per region. Your competitors cannot access this system. First mover locks the territory.
| Traditional Model | Renagen Model | |
|---|---|---|
| Revenue type | One-time per visit | Recurring (processing + annual storage) |
| Upfront investment | Significant | Renagen-supported deployment |
| Lab staff | You hire and train | Renagen-trained biologist on-site |
| Collection | Invasive procedure | Non-invasive |
| Protocol support | Full internal responsibility | Shared with Renagen |
| Exclusivity | None | Regional exclusivity |
From first call to operational in 90 days.
Renagen handles the entire deployment in coordination with your clinical team. You provide the space and clinical oversight. We implement, train, and support operations.
Evaluation Call
We assess your clinic profile, patient volume, available space, and regional exclusivity.
Pilot Agreement
A 90-day pilot programme with 10 to 20 patients. Physician-supervised. Full documentation provided. Stop at any time.
System Deployment
Equipment installation, SOP training, quality system setup, and on-site biologist placement.
Ongoing Operation
Renagen manages processing, quality control, and biobank maintenance. You focus on patients and revenue.
Simple. Standardized. Non-invasive.
The workflow is implemented in coordination with your clinical team and under your institution's medical oversight. Renagen handles operational logistics. Your team retains full clinical authority over the patient.
Sample Collection
Non-invasive urine collection at your clinic. No surgery, no anaesthesia, no recovery time.
Processing
On-site biologist isolates and expands cells following standardized SOPs. Controlled environment. Full batch documentation.
Quality Verification
Cell count, viability, sterility, and surface marker validation. Release only when all quality gates are passed.
Clinical Application
Your physician determines the protocol. All clinical decisions remain with your medical team.
| Feature | Traditional Sources | Renagen System |
|---|---|---|
| Collection | Invasive procedure | Non-invasive |
| Patient burden | Moderate | Minimal |
| Setup | Dedicated surgical environment | Structured in-clinic program |
| Workflow location | External lab | Workflow-based integration in your clinic |
| Scalability | Limited by procedure capacity | High, via simplified collection |
Turn every patient into a recurring revenue account.
Cryopreservation of autologous cells creates long-term value. Patients bank their cells today for potential future use. Your clinic earns an annual storage fee for every active biobank account.
This is not a one-time transaction. It is a patient lifecycle asset that generates income year after year while deepening patient loyalty to your practice.
Request Strategic Partner Call
Start with a 90-day pilot. No financial commitment.
We understand this is new. That is why every partnership begins with a structured pilot programme designed to validate the model inside your clinic before any long-term commitment.
- 10 to 20 patients under physician supervision
- Full SOP documentation and training
- Renagen biologist on-site
- Complete quality and traceability records
- Stop at any time
We review a limited number of clinics each quarter. Regional exclusivity is allocated selectively. If your territory is still available, the window is now.
Check Regional Availability
Is your clinic eligible?
We are currently reviewing a limited number of clinics for regional partnership in Mexico, Panama, Colombia, and select LATAM markets. Strategic partner selection is limited by territory.
Requirements
- Private clinic or hospital with active patient flow
- Active practice in regenerative or orthopaedic services
- 25 to 40 m2 of available space
- Physician willing to supervise the pilot
